AGAP3 and cutaneous mastocytosis: In the base model without CrAg screening, 305 patients with a CD4 <100 cells/μL develop CM without screening, 41% (126/305) are ART-naïve, and 196 CM-related deaths occur, with an additional 22 relapse CM cases (Table 3).